1. Home
  2. DXCM vs STT Comparison

DXCM vs STT Comparison

Compare DXCM & STT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DXCM
  • STT
  • Stock Information
  • Founded
  • DXCM 1999
  • STT 1792
  • Country
  • DXCM United States
  • STT United States
  • Employees
  • DXCM N/A
  • STT N/A
  • Industry
  • DXCM Medical/Dental Instruments
  • STT Major Banks
  • Sector
  • DXCM Health Care
  • STT Finance
  • Exchange
  • DXCM Nasdaq
  • STT Nasdaq
  • Market Cap
  • DXCM 28.0B
  • STT 27.7B
  • IPO Year
  • DXCM 2005
  • STT N/A
  • Fundamental
  • Price
  • DXCM $77.72
  • STT $98.37
  • Analyst Decision
  • DXCM Buy
  • STT Buy
  • Analyst Count
  • DXCM 17
  • STT 14
  • Target Price
  • DXCM $101.29
  • STT $95.07
  • AVG Volume (30 Days)
  • DXCM 3.9M
  • STT 1.9M
  • Earning Date
  • DXCM 02-06-2025
  • STT 01-17-2025
  • Dividend Yield
  • DXCM N/A
  • STT 3.09%
  • EPS Growth
  • DXCM 83.21
  • STT N/A
  • EPS
  • DXCM 1.67
  • STT 6.30
  • Revenue
  • DXCM $3,954,000,000.00
  • STT $12,548,000,000.00
  • Revenue This Year
  • DXCM $13.10
  • STT N/A
  • Revenue Next Year
  • DXCM $14.79
  • STT $3.22
  • P/E Ratio
  • DXCM $46.61
  • STT $15.61
  • Revenue Growth
  • DXCM 16.19
  • STT 4.38
  • 52 Week Low
  • DXCM $62.34
  • STT $70.20
  • 52 Week High
  • DXCM $142.00
  • STT $99.76
  • Technical
  • Relative Strength Index (RSI)
  • DXCM 56.89
  • STT 62.53
  • Support Level
  • DXCM $77.50
  • STT $96.69
  • Resistance Level
  • DXCM $82.26
  • STT $99.76
  • Average True Range (ATR)
  • DXCM 2.42
  • STT 1.32
  • MACD
  • DXCM 0.20
  • STT -0.11
  • Stochastic Oscillator
  • DXCM 53.44
  • STT 73.22

About DXCM DexCom Inc.

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

About STT State Street Corporation

State Street is a leading provider of financial services, including investment servicing, investment management, and investment research and trading. With approximately $42 trillion in assets under custody and administration and $4.1 trillion assets under management as of Dec. 31, 2023, State Street operates globally in more than 100 geographic markets and employs more than 46,000 worldwide.

Share on Social Networks: